Erika A Petersen
Erika A Petersen
Up to 25% of people with diabetes develop painful diabetic neuropathy (PDN). The standard of care pharmacotherapies for PDN have limited efficacy with a considerable side effect profile. Spinal cord stimulation (SCS) is a form of electrical...
Conventional management and current guidelines for painful diabetic neuropathy [0.03%]
疼痛性糖尿病神经病变的常规管理和现行指南
Solomon Tesfaye,Peter Kempler
Solomon Tesfaye
Painful Diabetic Peripheral Neuropathy (PDN) is common, affecting around a quarter of patients with both type 1 and type 2 diabetes, and can lead to significant curtailment of functionality and quality of life. Patients may present with unr...
Health-related quality of life and spinal cord stimulation in painful diabetic neuropathy [0.03%]
疼痛性糖尿病神经病变中的健康相关生活质量与脊髓刺激
Rod S Taylor
Rod S Taylor
Peripheral neuropathic pain, including painful diabetic neuropathy (PDN), is associated with marked negative impact on health-related quality of life (HRQoL). The magnitude of reduction of HRQoL experienced by individual PDN patients appear...
Quality of life of persons with painful diabetic neuropathy: How can we improve it? [0.03%]
糖尿病性疼痛神经病变患者的生活质量：我们如何改善它？
Loretta Vileikyte
Loretta Vileikyte
Painful diabetic neuropathy (PDN) is difficult to treat, with pharmacological treatments providing only partial pain relief that is limited by medication side effects. This necessitates a holistic approach to pain control,with pharmacologic...
Thorsten D Luecke
Thorsten D Luecke
High frequency spinal cord stimulation (SCS) is a safe and effective treatment option for refractory painful diabetic neuropathy and should be considered for use early in the course of the disease. Raising awareness of this minimally invasi...
The pathogenesis of painful diabetic neuropathy and clinical presentation [0.03%]
疼痛性糖尿病神经病变的发病机制和临床表现
Troels Staehelin Jensen
Troels Staehelin Jensen
Diabetic neuropathy is a common complication of diabetes that affects up to 50% of patients during the course of the disease; 20-30% of the patients also develop neuropathic pain. The mechanisms underlying neuropathy are not known in detail...
De-escalating treatment indications for patients who achieve metabolic goals [0.03%]
达到代谢目标的患者的降级治疗指征
Ana Cristina García-Ulloa,Salvador Jaime-Casas,Johanna Rosado-Lozoya et al.
Ana Cristina García-Ulloa et al.
Introduction: Robust evidence exists regarding initiation, intensification or modification of treatments. Recommendations to de-escalate therapy are lacking, specifically in diabetes. A successful treatment de-intensifica...
Incidence and prevalence of type 2 diabetes in Manitoba children 2009-10 to 2017-18: First Nation versus all other Manitobans [0.03%]
2009-10至2017-18年马尼托巴地区儿童2型糖尿病的发病率和流行率：第一民族与所有其他马尼托巴人的比较
Elizabeth A C Sellers,Lorraine McLeod,Heather J Prior et al.
Elizabeth A C Sellers et al.
Aim: To describe the incidence and prevalence of type 2 diabetes in children in Manitoba over a ten-year period. Methods: Population-ba...
Glucometric benchmarking to aid refinement of multi-element peri-operative models of care [0.03%]
用于改进围手术期多模式护理的血糖基准优化
Rahul D Barmanray,Ji Won Susie Yoo,Mervyn Kyi et al.
Rahul D Barmanray et al.
Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: A nationwide population-based study [0.03%]
2型糖尿病诊断年龄与心血管病残和死亡风险的关联：一项全国性人群基础研究
Da Hea Seo,Mina Kim,Young Ju Suh et al.
Da Hea Seo et al.
Aims: We aimed to investigate the association between the age at diagnosis of type 2 diabetes and the risk of cardiovascular (CVD) outcomes in comparison with nondiabetic counterparts. ...